Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo likes Lance a lot: Sean Lance to succeed CEO Sykes in 1998.

Executive Summary

GLAXO WELLCOME CEO-DESIGNATE LANCE HEADS INTERNATIONAL BUSINESS of Glaxo Wellcome as managing director of Glaxo Wellcome, plc. Sean Lance, 49, will succeed Richard Sykes, PhD, as chief executive of Glaxo Wellcome at the 1998 annual general meeting. Sykes, currently deputy chairman and chief executive, will assume the chairman spot upon the retirement of Colin Corness in May 1997 and fill both roles for a year.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029633

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel